Cargando…

Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Chronic stable angina (CSA) resulted in a considerable burden for both individuals and the society. In this study we aimed to critically evaluate the effectiveness and safety of Compound salvia pellet compared with nitrates in the treatment of Chronic Stable Angina (CSA) pectoris, and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Huiping, Wei, Yu, Wang, Pei, Jin, Jiao, Li, Shian, Zhang, Hugang, Jiang, Zheng, Wang, Yingdong, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831215/
https://www.ncbi.nlm.nih.gov/pubmed/30817582
http://dx.doi.org/10.1097/MD.0000000000014638
_version_ 1783465917306372096
author Huiping, Wei
Yu, Wang
Pei, Jin
Jiao, Li
Shian, Zhang
Hugang, Jiang
Zheng, Wang
Yingdong, Li
author_facet Huiping, Wei
Yu, Wang
Pei, Jin
Jiao, Li
Shian, Zhang
Hugang, Jiang
Zheng, Wang
Yingdong, Li
author_sort Huiping, Wei
collection PubMed
description BACKGROUND: Chronic stable angina (CSA) resulted in a considerable burden for both individuals and the society. In this study we aimed to critically evaluate the effectiveness and safety of Compound salvia pellet compared with nitrates in the treatment of Chronic Stable Angina (CSA) pectoris, and to provide more credible evidence for clinical practice. METHODS: A comprehensive and exhaustive search strategy was formulated to identify potential RCTs of compound salvia pellet for CSA in international and Chinese databases from their inception to July 4th, 2018. We also searched the bibliographies of relevant studies. Two reviewers independently assessed the quality of included trials by using Cochrane Risk of Bias Tool. RESULTS: The literature search yielded 1849 citations and 51 RCTs (n = 4732) were included for meta-analysis after titles, abstracts and full text selection according to eligibility criteria. The pooled results suggested that compound salvia pellet was much more effective than nitrates in the improvement of angina symptoms (therapy = 4 weeks, RR = 1.23, 95%CI = [1.17, 1.30], P < .001, I(2) = 0%; therapy = 4 weeks, RR = 1.13, 95%CI = [1.08, 1.17], P < .001, I(2) = 45.6%), and ECG test (therapy = 4 weeks, RR = 1.24, 95%CI [1.14, 1.35], P < .001, I(2) = 51.5%; and therapy > 4 weeks, RR = 1.30, 95%CI[1.20, 1.42], P < .001, I(2) = 36.4%) in CSA. Compared with nitrates, the percentage of patients with adverse events significantly decreased when prescribed with compound salvia pellet (3.2% vs 17.0%). CONCLUSION: Compound salvia pellet might be more effective on the improvement of angina symptoms, ECG test and with few adverse events compared with nitrates. While there are some limitations in this study, which may weaken the results, we believe the findings could provide useful information for stakeholders concerned with outcomes in patients with CSA. More rigorous RCTs with high quality are needed to confirm these findings.
format Online
Article
Text
id pubmed-6831215
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68312152019-11-19 Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials Huiping, Wei Yu, Wang Pei, Jin Jiao, Li Shian, Zhang Hugang, Jiang Zheng, Wang Yingdong, Li Medicine (Baltimore) 3800 BACKGROUND: Chronic stable angina (CSA) resulted in a considerable burden for both individuals and the society. In this study we aimed to critically evaluate the effectiveness and safety of Compound salvia pellet compared with nitrates in the treatment of Chronic Stable Angina (CSA) pectoris, and to provide more credible evidence for clinical practice. METHODS: A comprehensive and exhaustive search strategy was formulated to identify potential RCTs of compound salvia pellet for CSA in international and Chinese databases from their inception to July 4th, 2018. We also searched the bibliographies of relevant studies. Two reviewers independently assessed the quality of included trials by using Cochrane Risk of Bias Tool. RESULTS: The literature search yielded 1849 citations and 51 RCTs (n = 4732) were included for meta-analysis after titles, abstracts and full text selection according to eligibility criteria. The pooled results suggested that compound salvia pellet was much more effective than nitrates in the improvement of angina symptoms (therapy = 4 weeks, RR = 1.23, 95%CI = [1.17, 1.30], P < .001, I(2) = 0%; therapy = 4 weeks, RR = 1.13, 95%CI = [1.08, 1.17], P < .001, I(2) = 45.6%), and ECG test (therapy = 4 weeks, RR = 1.24, 95%CI [1.14, 1.35], P < .001, I(2) = 51.5%; and therapy > 4 weeks, RR = 1.30, 95%CI[1.20, 1.42], P < .001, I(2) = 36.4%) in CSA. Compared with nitrates, the percentage of patients with adverse events significantly decreased when prescribed with compound salvia pellet (3.2% vs 17.0%). CONCLUSION: Compound salvia pellet might be more effective on the improvement of angina symptoms, ECG test and with few adverse events compared with nitrates. While there are some limitations in this study, which may weaken the results, we believe the findings could provide useful information for stakeholders concerned with outcomes in patients with CSA. More rigorous RCTs with high quality are needed to confirm these findings. Wolters Kluwer Health 2019-03-01 /pmc/articles/PMC6831215/ /pubmed/30817582 http://dx.doi.org/10.1097/MD.0000000000014638 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Huiping, Wei
Yu, Wang
Pei, Jin
Jiao, Li
Shian, Zhang
Hugang, Jiang
Zheng, Wang
Yingdong, Li
Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials
title Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials
title_full Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials
title_fullStr Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials
title_short Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials
title_sort compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: a systematic review and meta-analysis of randomized controlled trials
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831215/
https://www.ncbi.nlm.nih.gov/pubmed/30817582
http://dx.doi.org/10.1097/MD.0000000000014638
work_keys_str_mv AT huipingwei compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT yuwang compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT peijin compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT jiaoli compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT shianzhang compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT hugangjiang compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhengwang compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT yingdongli compoundsalviapelletmightbemoreeffectiveandsaferforchronicstableanginapectoriscomparedwithnitratesasystematicreviewandmetaanalysisofrandomizedcontrolledtrials